Video | 04 April 2022 Why we’re asking governments to reject the leaked text on COVID-19 at the WTO COVID-19 Leena Menghaney outlines why the leaked TRIPS Waiver doesn't go anywhere near far enough in terms of addressing the development of COVID-19 treatments, vaccines and diagnostics. Read, watch, share Filter by - Any -BlogEventsExplainerFeature storyInterviewIssue briefLetterNewsletterOpinion articlePress releaseSpeechSpotlightStatementTechnical briefVideo Blog Blog | 29 November 2021 COVID-19 mAbs: Gamechangers for this pandemic — and beyond Photograph by Paul Odongo Press release Press release | 16 November 2021 COVID-19 MSF response to license between Pfizer and Medicines Patent Pool for new COVID-19 treatment Paxlovid 4 min Statement | 11 November 2021 COVID-19 MSF position on the scope and duration of the TRIPS waiver for COVID-19 Video Video | 10 November 2021 COVID-19 Local production of diagnostics to meet health needs in Asia Video Video | 08 November 2021 COVID-19 MSF staff call out the injustice of unfair access to COVID-19 vaccines Photograph by Chris Allan Press release Press release | 04 November 2021 COVID-19 As Moderna releases astronomical Q3 sales figures, MSF tells the corporation it’s high time to share the technology with WHO mRNA vaccine tech transfer Hub in South Africa 5 min Photograph by Mariana Abdalla Press release Press release | 04 November 2021 COVID-19 MSF response to first regulatory approval of first oral antiviral treatment for COVID-19, molnupiravir 2 min Newsletter Newsletter | 04 November 2021 COVID-19 No profit in a pandemic! Moderna must share COVID-19 vaccine technology now Load More
Photograph by Paul Odongo Press release Press release | 16 November 2021 COVID-19 MSF response to license between Pfizer and Medicines Patent Pool for new COVID-19 treatment Paxlovid 4 min
Statement | 11 November 2021 COVID-19 MSF position on the scope and duration of the TRIPS waiver for COVID-19
Video Video | 08 November 2021 COVID-19 MSF staff call out the injustice of unfair access to COVID-19 vaccines
Photograph by Chris Allan Press release Press release | 04 November 2021 COVID-19 As Moderna releases astronomical Q3 sales figures, MSF tells the corporation it’s high time to share the technology with WHO mRNA vaccine tech transfer Hub in South Africa 5 min
Photograph by Mariana Abdalla Press release Press release | 04 November 2021 COVID-19 MSF response to first regulatory approval of first oral antiviral treatment for COVID-19, molnupiravir 2 min
Newsletter Newsletter | 04 November 2021 COVID-19 No profit in a pandemic! Moderna must share COVID-19 vaccine technology now
